Biotech by P/B ratio

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Kodiak Sciences leads the 18 biotech ranked by P/B ratio, at 494, ahead of Scholar Rock Holding (32.6) and Adaptive Biotechnologies (26.1). Figures as of 18 Nov 2026, 13:34 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
18
First
Kodiak Sciences494
Median
8.8
Combined market value
$849.1B
Countries
5
Not ranked
6no P/B ratio on file

Market values as of .

Biotech by P/B ratio
#CompanyP/B ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Kodiak SciencesKOD · Health Care494$6.3B$96.80 3.90% down 396% up United States
2Scholar Rock HoldingSRRK · Health Care32.6$5.5B$45.08 1.21% up 14% up United States
3Adaptive BiotechnologiesADPT · Health Care26.1$4.6B$28.49 2.22% up 88% up United States
4AmgenAMGN · Health Care17.3$247.7B$457.93 0.95% down 34% up United States
5Gilead SciencesGILD · Health Care16.2$211.2B$170.26 1.60% up 33% up United States
6Revolution MedicinesRVMD · Health Care14.7$35.2B$162.69 2.50% down 131% up United States
7ModernaMRNA · Health Care12.2$83.7B$206.80 3.93% down 755% up United States
8ImmunovantIMVT · Health Care10.5$6.9B$33.21 0.21% down 43% up United States
9ExelixisEXEL · Health Care9.1$16.7B$68.50 2.09% up 63% up United States
10Twist BioscienceTWST · Health Care8.6$7.6B$112.00 6.63% up 340% up United States
11CG OncologyCGON · Health Care7.1$7.1B$78.94 6.89% down 85% up United States
12Kymera TherapeuticsKYMR · Health Care6.4$10.4B$121.52 3.44% down 87% up United States
13Krystal BiotechKRYS · Health Care6.2$8.8B$298.55 0.22% up 46% up United States
14Bio-TechneTECH · Health Care5.3$11.4B$72.63 0.22% down 26% up United States
15RepligenRGEN · Health Care4.4$10.4B$162.18 0.37% down 5% up United States
16Neurocrine BiosciencesNBIX · Health Care4.3$16.8B$165.92 0.37% up 20% up United States
17VaxcytePCVX · Health Care3.6$9.4B$59.40 3.59% down 22% up United States
18BiogenBIIB · Health Care2.0$37.1B$250.79 0.34% down 49% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. 6 companies have no P/B ratio on file and are not ranked here.

Questions and answers

Which biotech rank first by P/B ratio?

Kodiak Sciences (494), Scholar Rock Holding (32.6) and Adaptive Biotechnologies (26.1) are the top three of the 18 biotech ranked by P/B ratio as of 18 Nov 2026, 13:34 UTC.

How many biotech are in this ranking?

18 are ranked by P/B ratio. 6 more have no P/B ratio on file and are left out rather than ranked at zero.

What are these biotech worth together?

The 18 biotech ranked by P/B ratio have a combined market value of $849.1B as of 18 Nov 2026, 13:34 UTC.

What does ranking by P/B ratio measure?

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Cite this page

Funkfolio, “Biotech by P/B ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=pb-ratio

Underlying data: Yahoo Finance; SEC EDGAR.